story of the week
Pemigatinib for Previously Treated, Locally Advanced or Metastatic Cholangiocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pemigatinib for Previously Treated, Locally Advanced or Metastatic Cholangiocarcinoma: A Multicentre, Open-Label, Phase 2 Study
Lancet Oncol 2020 Mar 20;[EPub Ahead of Print], GK Abou-Alfa, V Sahai, A Hollebecque, G Vaccaro, D Melisi, R Al-Rajabi, AS Paulson, MJ Borad, D Gallinson, AG Murphy, DY Oh, E Dotan, DV Catenacci, E Van Cutsem, T Ji, CF Lihou, H Zhen, L Féliz, A VogelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.